Structural and functional characterization of platelet receptor-mediated factor VIII binding

Area of Science:

• Biochemistry
• Hematology
• Molecular Biology

Background:

• Optimal factor X (FX) activation necessitates specific receptor interactions on activated platelets.
• Factor VIII (FVIII) and FX presence enhances factor IXa (FIXa) affinity for platelets.
• FVIII or FVIIIa creates high-affinity FX-binding sites on activated platelets.

Purpose of the Study:

• To investigate the effects of FX and inhibited FIXa on FVIII and FVIIIa binding to activated platelets.
• To elucidate the specific interactions and regulatory factors involved in the FX activation complex formation on platelet surfaces.

Main Methods:

• Studied the binding kinetics of FVIII and FVIIIa to activated platelets under various conditions.
• Utilized specific inhibitors and agonists (e.g., von Willebrand factor, thrombin, Annexin V) to probe binding mechanisms.
• Quantified receptor affinity (Kd) and number (n) for FVIII and FVIIIa on platelets.

Main Results:

• Von Willebrand factor inhibited FVIII binding but not FVIIIa binding.
• Thrombin and its receptor activation peptide potently induced FVIII-binding sites; ADP was ineffective.
• FVa did not compete for FVIII/FVIIIa binding sites, while Annexin V inhibited FVIIIa binding.
• FVIII and FVIIIa exhibit specific, saturable, and reversible binding to distinct high-affinity platelet receptors.
• EGR-FIXa and FX increased the number and affinity of FVIII/FVIIIa binding sites, supporting a three-receptor model.

Conclusions:

• FVIII and FVIIIa binding to activated platelets is specific and regulated by various factors.
• The A2 domain of FVIII is important for FVIIIa binding affinity and complex stability.
• Findings support a three-receptor model for the FX activation complex assembly on platelet surfaces, crucial for hemostasis.